Report Overview

Indian Topical & Transdermal Products for Pain Management Therapeutics Market size stood at around USD XX Billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around XX% during the forecast period.

India is the fastest growing pain management market owing to a huge patient pool, increasing demand for treatments, and increasing healthcare expenditure.The growth of the Indian Topical & Transdermal for Pain Management market is majorly due to the well-established business of painkiller medications as the first line of treatment.The current market is gradually adopting more non-opioid medications, to suppress the addiction toward opioids and certain well-established painkillers in the market.Post-surgical pain is one of the primary focuses of hospitals, where the cost of monitoring and the treatment of adverse effects create the major demand for pain management drugs and devices. Rising cases of cancer pain indication are expected to drive the market during the forecasting period. Also, opioids drugs will have the highest sales in the market shortly.



Market Driving and Restraining Factors

Driving Factors

Rise in geriatric population, surge in prevalence of chronic diseases, such as cancer, diabetic neuropathy, and osteoarthritis propels the market growth, rise in healthcare expenditure, growth in awareness regarding diseases, enhancing healthcare infrastructure, research and development activities and surge in healthcare expenditure positively affect the pain management therapeutics market, rise in number of surgical procedures and rise in healthcare expenditure are expected to fuel growth of the topical & transdermal products for pain management drugs market.

Restraining Factors

On the other hand, the restraining factors are the rising concerns regarding drug exploitation and patent expiration of prescription pain medication drugs are the factors expected to obstruct the topical & transdermal products for pain management therapeutics market growth.